Euda Health Holdings Stock Price To Book
| EUDA Stock | 4.39 0.07 1.62% |
EUDA Health Holdings fundamentals help investors to digest information that contributes to EUDA Health's financial success or failures. It also enables traders to predict the movement of EUDA Stock. The fundamental analysis module provides a way to measure EUDA Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EUDA Health stock.
As of November 27, 2024, Price To Book Ratio is expected to decline to -4.59. EUDA | Price To Book |
EUDA Health Holdings Company Price To Book Analysis
EUDA Health's Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.
EUDA Price To Book Driver Correlations
Understanding the fundamental principles of building solid financial models for EUDA Health is extremely important. It helps to project a fair market value of EUDA Stock properly, considering its historical fundamentals such as Price To Book. Since EUDA Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of EUDA Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of EUDA Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
| Competition |
EUDA Book Value Per Share
Book Value Per Share |
|
Based on the latest financial disclosure, EUDA Health Holdings has a Price To Book of 0.0 times. This is 100.0% lower than that of the Health Care Equipment & Supplies sector and about the same as Health Care (which currently averages 0.0) industry. The price to book for all United States stocks is 100.0% higher than that of the company.
EUDA Price To Book Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EUDA Health's direct or indirect competition against its Price To Book to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EUDA Health could also be used in its relative valuation, which is a method of valuing EUDA Health by comparing valuation metrics of similar companies.EUDA Health is currently under evaluation in price to book category among its peers.
EUDA Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, EUDA Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to EUDA Health's managers, analysts, and investors.Environmental | Governance | Social |
EUDA Fundamentals
| Return On Asset | -0.86 | ||||
| Operating Margin | (0.83) % | ||||
| Current Valuation | 165.48 M | ||||
| Shares Outstanding | 37.15 M | ||||
| Shares Owned By Insiders | 49.35 % | ||||
| Shares Owned By Institutions | 2.47 % | ||||
| Number Of Shares Shorted | 5.04 K | ||||
| Price To Sales | 42.79 X | ||||
| Revenue | 3.71 M | ||||
| Gross Profit | 3.35 M | ||||
| EBITDA | (8.3 M) | ||||
| Net Income | (8.43 M) | ||||
| Total Debt | 3.37 M | ||||
| Book Value Per Share | (0.17) X | ||||
| Cash Flow From Operations | (2.92 M) | ||||
| Short Ratio | 0.07 X | ||||
| Earnings Per Share | (0.62) X | ||||
| Target Price | 6.0 | ||||
| Number Of Employees | 106 | ||||
| Beta | -0.004 | ||||
| Market Capitalization | 163.1 M | ||||
| Total Asset | 1.31 M | ||||
| Retained Earnings | (34.74 M) | ||||
| Working Capital | (7.99 M) | ||||
| Net Asset | 1.31 M |
About EUDA Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EUDA Health Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EUDA Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EUDA Health Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether EUDA Health Holdings is a strong investment it is important to analyze EUDA Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact EUDA Health's future performance. For an informed investment choice regarding EUDA Stock, refer to the following important reports:Check out EUDA Health Piotroski F Score and EUDA Health Altman Z Score analysis. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EUDA Health. If investors know EUDA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EUDA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.62) | Revenue Per Share 0.144 | Quarterly Revenue Growth (0.14) | Return On Assets (0.86) |
The market value of EUDA Health Holdings is measured differently than its book value, which is the value of EUDA that is recorded on the company's balance sheet. Investors also form their own opinion of EUDA Health's value that differs from its market value or its book value, called intrinsic value, which is EUDA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EUDA Health's market value can be influenced by many factors that don't directly affect EUDA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EUDA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if EUDA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EUDA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.